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ABSTRACT 
In the current study, oligo(poly(ethylene glycol) fumarate) (OPF)-based hydrogels were tested 
for the first time as injectable bone substitute materials. The primary feature of the material 
design was the incorporation of calcium phosphate (CaP) nanoparticles within the polymeric 
matrix in order to compare the soft tissue response and bone forming capacity of plain OPF 
hydrogels with CaP-enriched OPF hydrogel composites. To that end, pre-set scaffolds were 
implanted subcutaneously, whereas flowable polymeric precursor solutions were injected in a 
tibial ablation model in guinea pigs. After 8 weeks of implantation, histological and 
histomorphometrical evaluation of the subcutaneous scaffolds confirmed the biocompatibility 
of both types of hydrogels. Nevertheless, OPF hydrogels presented a loose structure, massive 
cellular infiltration and extensive material degradation compared to OPF-CaP hydrogels that 
were more compact. MicroCT, histological and histomorphometrical analyses showed 
comparable amount of new trabecular bone in all tibias and some material remnants in the 
medial and distal regions. Particularly, highly calcified areas were observed in the distal 
region of OPF-CaP treated tibias. These results indicate that CaP nanoparticles agglomerated 
and left sediment, resulting into a heterogeneous distribution of the mineral phase throughout 
the hydrogel matrix. This phenomenon can be attributed to either hindered gelation under 
highly perfused in vivo conditions or a faster degradation rate of the polymeric hydrogel 
matrix compared to the nanostructured mineral phase resulting into loss of entrapment of the 
CaP nanoparticles and subsequent sedimentation.  
 
Keywords: 
Hydrogels; calcium phosphate nanoparticles; injectable; animal model; bone formation.
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1. Introduction 
 
The growing incidence of bone loss and injuries as a result of an increasing elderly 
population combined with accidental trauma and diseases represent a problem with major 
social importance and significant economical burden on the health care system. This critical 
situation has led researchers in the field of regenerative medicine to focus on the development 
of synthetic biomaterials for bone regeneration, which provide temporary support to missing 
or damaged tissue while inducing and directing the regeneration of new healthy bone tissue 
[1].  
The selection of appropriate biomaterials for bone repair depends on the clinical application 
(e.g. load-bearing or non-load-bearing) and requires consideration of several fundamental 
requirements, including biocompatibility, biodegradability, ability to promote bone formation 
and, ultimately, to regenerate bone marrow [2,3]. An appealing direction for the treatment of 
bone defects under non-load-bearing conditions is the application of injectable and readily 
available (“off the shelf”) biomaterials. From a clinical perspective, the use of injectable 
biomaterials is attractive as it allows a minimally invasive surgical approach, which reduces 
both patient discomfort and cost of treatment. In addition, injectable biomaterials provide 
many advantages over pre-shaped materials (e.g. granules and blocks), including optimal 
defect filling with direct contact between biomaterial and surrounding tissue [4]. Hydrogels 
are a class of polymer-based biomaterials which fulfill all the aforementioned requirements. 
These highly hydrated polymer networks are injectable, biodegradable as well as 
biocompatible due to their high water content. As a result, hydrogels can act as artificial 
extracellular matrices (ECM) which provide a temporary three dimensional (3D) environment 
suitable for cell colonization and eventual tissue regeneration [5]. Originally, hydrogels were 
mainly considered as fillers for soft tissues. Recently, however, hydrogels are also considered 
for hard tissue regeneration in the field of orthopedics as well as oral and maxillofacial 
surgery. To that end, hydrogels are currently functionalized using different strategies, 
including bioactive agents (e.g. calcium phosphate nanocrystals, bioglasses), enzymes or 
growth factors [6]. 
Among synthetic hydrogel-based materials, oligo(poly(ethylene glycol) fumarate) (OPF) 
hydrogels have been extensively explored for cartilage and bone tissue regeneration 
applications both in vitro and in vivo [7-10]. Structurally, OPF polymers are composed of two 
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repeating units, poly(ethylene glycol) (PEG) and fumaric acids, which are alternately linked 
by ester bonds and can be degraded through hydrolytic cleavage [11]. OPF gelation, i.e. the 
transition from flowable polymer precursor solution to hydrogel, occurs upon chemical cross-
linking of macromers in a 10-15 minute time period and at 37°C [12,13]. These properties 
will potentially allow clinicians to prepare the material directly in the operating theatre, inject 
it into the desired site through a small incision, and close the wound after in situ gelation. 
Moreover, it has been shown that the choice of oligomer length and crosslinking agents offers 
versatile swelling characteristics as well as  
Since bone mainly consists of calcium phosphate nanocrystals (~70 wt%), the incorporation 
of CaP nanoparticles into polymeric hydrogels is a straightforward approach to stimulate the 
formation of new bone by the surrounding tissue [15]. Recently, we showed that CaP 
nanoparticle-enriched OPF hydrogels also have a stimulatory effect on mineralized matrix 
production by encapsulated rat osteoblast-like stem cells (OBLCs) in vitro [16]. This 
advantage of OPF-CaP hydrogels suggests their potential for application as a bone substitute 
material.  
The present study was designed to test the biological performance of OPF-based hydrogels, 
either or not enriched with CaP nanoparticles, in a guinea pig model. To that end, OPF-based 
hydrogels were ectopically implanted at a subcutaneous location in a pre-set form to assess 
biocompatibility and injected in the tibial medullary cavity to evaluate osteogenic responses. 
Specifically, the ease of the surgical procedure and the adequate dimensions of the tibial 
medullary cavity of guinea pigs for material injection encouraged the selection of this model. 
Moreover, taking into account the advantage of the rapid endosteal bone formation that occurs 
following injury to the marrow cavity of tibial bone [17], we hypothesized that CaP-enriched 
OPF hydrogels would enhance bone formation capacity compared to the plain OPF hydrogels. 
 
2. Materials and methods 
 
2.1. Materials 
Oligo(PEG fumarate) with PEG nominal molecular weight of 10,000 g/mol was synthesize 
as previously described [18]. Poly(ethylene glycol) diacrylate (PEGDA, nominal molecular 
weight 3400) was obtained from Glycosan Biosystem (Salt Lake City UT, USA). N,N,N ,N -
tetramethylethylenediamine (TEMED) was purchased from Fluka (Buchs, Switzerland). 
Ammonium persulfate (APS) and phosphate-buffered saline pH 7.4 (PBS) were purchased 
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from Sigma-Aldrich (St. Louis MO, USA). Fumaryl chloride, phosphoric acid (H3PO4) and 
calcium hydroxide (Ca(OH)2) were acquired from Acros (Pittsburgh PA, USA). 
 
2.2. CaP nanoparticles preparation 
 
A homogeneous suspension of nano-sized calcium phosphate (CaP) particles was prepared 
according to a wet-chemical precipitation process as previously described [16]. In order to 
mimic the physiological condition, H3PO4 (3.56 M) and Ca(OH)2 (5.92 M) were prepared in 
PBS, and the precursors compounds were used at a stoichiometric Ca/P ratio of 1.67 to obtain 
a final solid content of ~ 0.3 g/ml (30% w/v). This method resulted in stable needle-shaped 
hydroxyapatite nanoparticles with an average length of 76 nm and a diameter of 19 nm, and 
minor traces of monetite as a secondary CaP phase, as confirmed by XRD and TEM [16].  
 
2.3. Experimental groups 
 
In this animal study, a total of 3 experimental groups were used. Table 1 shows the number 
of subcutaneous scaffolds and injection into the tibial medullary cavities for each 
experimental group. Specifically, a total of 32 scaffolds were prepared and 16 hydrogel 
injections were performed. Sham-operated group received neither subcutaneous scaffolds nor 
material injection in the tibial medullary cavity. 
The composition of OPF-based hydrogel scaffolds is depicted in Table 2 and synthesis was 
carried out as previously described by Kinard and co-workers [18]. In the same paper, cross-
linking methods for OPF hydrogels have been thoroughly described. Briefly, OPF hydrogels 
can be formed by radical polymerization in the presence of either a thermally induced or 
ultraviolet-induced radical initiator. In addition, cross-linking molecules are used in OPF 
hydrogel fabrication to reduce cross-linking time and provide suitable handling characteristics 
for injectable applications. In the current study, OPF polymers were combined with PEGDA 
cross-linkers, and hydrogels were formed by radical polymerization in the presence of 
thermally induced radical initiators, i.e. the water-soluble redox pairs ammonium 
persulfate/N,N,N′,N′-tetramethylethylenediamine (APS/TEMED). In view of that, the 
temperature was a key factor in controlling the gelation time. 
For pre-set scaffolds, OPF and PEGDA were dissolved either in PBS (CaP-free) or CaP 
suspension (also in PBS, polymer/CaP ratio: 50/50) in order to prepare OPF and OPF-CaP 
hydrogels, respectively. The mixtures were shaken at room temperature for 30 minutes to 
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reach complete dissolution of polymers. Subsequently, filter sterilized (0.2 µm filter) redox 
initiators, APS and TEMED, were added in equal concentration of 0.3 M. Immediately, 30 µl 
of the polymer mixtures were injected into pre-sterilized Teflon molds (Ø 6 mm, 1 mm 
thickness) and incubated for 15 minutes at 37ºC. After gel formation, the hydrogels were 
transferred to 24-well plates and rinsed in sterile double-distilled water (ddH2O) for 2 days. 
For sterilization, the hydrogels were soaked in 70% ethanol for 3 days followed by immersion 
in sterile PBS for 3 days, changing the buffered solution once a day under sterile conditions, 
as previously described [9].  
For injectable hydrogel formulations, OPF and PEGDA were sterilized prior to use via 
exposure to ultraviolet light for 3 hours and freeze-dried overnight following an established 
technique [19]. The two components were then transferred in a 2.5 ml syringe under sterile 
conditions. In the operating room just prior to surgery, either sterilized PBS (for OPF) or CaP 
suspension (for OPF-CaP) was added and the mixtures were incubated at 37°C during the 
entire time of surgery in order to reach complete dissolution of polymers. When the tibia bone 
was ready for injection, sterile APS and TEMED, were added and the hydrogel solution was 
immediately injected. 
 
2.4. Animal model and surgical procedure 
 
The tibial marrow ablation model is an established model to study endosteal bone 
formation followed by bone marrow regeneration in mammals, such as rats, rabbits and 
guinea pigs [17,20-23]. In this study, the choice for the medullary cavity of guinea pigs for 
material injection was based on three preliminary facts: (1) two small holes are sufficient as 
an easily accessible site for injection; (2) the procedure ensures complete filling of the cavity 
using injectable materials, i.e. the outflow of the hydrogel material from the distal hole 
warrants complete filling; and (3) surgical procedures and material injection are reproducible, 
owing to a limited amount of surrounding soft tissues which enables easy manipulation and 
accessibility. Female animals were used because mature males are known to be aggressive 
toward unfamiliar adult males [24].  
Twenty-two adult female Dunkin-Hartley guinea-pigs (age: 7 month; mean body weight: 1 
kg) were included in this study. The guinea pigs were housed in three separate groups, with 
free access to food and water, and subjected to daily low-stress handling 1 month prior to 
surgery for reasons of accustoming [25]. The study was approved by the Animal Ethics 
Committee of Nijmegen, the Netherlands (DEC 2009-159) and national guidelines for animal 
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experimental work were obeyed. All surgical procedures were performed under general 
anesthesia and sterile conditions according to a previously described method [26]. Briefly, a 
full-thickness cortical defect (1.8 mm Ø) was performed in both distal (D) and proximal (P) 
sites of the right tibial diaphysis (Fig. 1a). After bone marrow evacuation (Fig. 1b), hydrogel 
solution, loaded in a 2.5-mL syringe connected to a catheter needle (BD VenflonTM Pro 1.8 x 
45mm, Becton Dickinson), was injected into the ablated tibial medullar cavity. The proximal 
hole served as entrance for injection and the distal one as evacuation site for hydrogel material 
to ensure complete filling (Fig. 1c). After injection, gelation was allowed for 15 minutes and 
confirmed by visual changes in hydrogel color and palpation of excess hydrogel material at 
the evacuation site. In sham-operated group control, the ablated medullary cavity was left 
empty to study the effect of ablation on bone regeneration. 
For the subcutaneous implantation of pre-set hydrogels, the dorsum of hydrogel-treated 
guinea pigs was shaved and disinfected with povidone iodine. Paravertebrally, two 
longitudinal incisions of about 15 mm were made through the full thickness of the skin, one 
on each side of the vertebral column. Subsequently, lateral to the incisions a subcutaneous 
pocket was created by blunt dissection with scissors. Preset hydrogels were placed in these 
pockets and the wounds were closed with resorbable sutures. Nor scaffold implantation or 
skin incisions were performed in sham-operated group. Postoperatively, antibiotics and 
analgesics were administered according to the established protocol. Animals were housed 
again in three separated groups with extra bedding to cushion the impact generated by 
walking and jumping, and given water and chow ad libitum. Moreover, animals were 
physically examined at regular intervals with focus on body weight, infections or adverse 
reactions. At 8 weeks post-implantation, all animals were euthanized. 
 
2.5. Processing of explanted subcutaneous scaffolds 
 
Immediately after euthanasia, subcutaneous implants with surrounding tissue were 
retrieved. The specimens were fixed in 10% neutral buffered formalin solution for 2 days and 
dehydrated through graded series of ethanol. Subsequently, each scaffold was cut in half and 
embedded in paraffin. 
 
2.5.1. Histological and histomorphometrical analysis 
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Six sections (6 µm) of each specimen were stained with haematoxylin and eosin (HE). 
Histological evaluation on all sections was performed using previously reported scoring 
methods [27]. Briefly, the parameters were fibrous capsule quality and fibrous capsule 
thickness, as a measure of cellular composition and maturity, and number of fibroblast layers 
surrounding the scaffolds, respectively (Table 3). The histological evaluation was done in four 
random fields along the scaffold–tissue interface using an optical microscope (Axio Imager 
Microscope Z1, Carl Zeiss Micro imaging GmbH, Göttingen, Germany) at a magnification of 
40X by two blinded evaluators. 
 
2.6. Processing of explanted tibia 
 
Treated tibias were harvested, excess tissue and epiphyses were removed, and the 
specimens were fixed in 10% neutral buffered formalin solution for 2 days and dehydrated in 
gradual series of alcohol from 70 to 100%. All samples were examined by microcomputed 
tomography (microCT), and histological and histomorphomethical analyses. In addition, six 
non-treated (left) tibias were retrieved and subjected to the same surgery and hydrogel 
injection ex vivo, in order to validate the animal model including assessment of the initial 
uniformity and quality of filling throughout the entire medullary cavity. These tibias were 
evaluated by microCT and histological analysis. 
 
2.6.1. Microcomputed tomography (microCT) 
 
MicroCT was performed on tibias to quantify the 3D microarchitecture of new bone 
within the medullary cavity. The specimens were wrapped in parafilm to prevent drying 
during scanning. Then, all tibia were scanned at an energy of 100 kV and intensity of 98 µA 
with a resolution of 15 µm using an aluminium filter (1 mm; Skyscan-1072 X-ray 
microtomograph, TomoNT version 3N.5, Skyscan®, Belgium). Each 3D image data set 
consisted of approximately 800 slice images with 16-bit gray level. Cone-Beam 
reconstruction of cross-section images from tomography projection images was performed 
(NRecon®, version 1.5.1.4, Skyscan), after which further analysis was performed by CT 
Analyzer (version 1.4, Skyscan®, Belgium). The volume of interest (VOI) was specified as 
the cylindrical area delimited by cortical bone and included within the two small holes 
(excluded). In this area, cavity volume (CV, mm3) and bone volume (BV, mm3) were used to 
calculate the bone volume to cavity volume ratio, expressed as a percentage (BV/CV, %). 
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2.6.2. Histological and histomorphometrical analysis 
 
After performing microCT imaging, all tibias were cut in 2 parts, i.e. a proximal (P) and a 
distal (D) part, which were alternately embedded in methyl methacrylate (MMA) or paraffin 
for histological analyses as depicted in Fig. 2. 
Half of the specimens (n = 11 proximal parts (P); and n = 11 distal parts (D)) were dehydrated 
in gradual series of alcohol and embedded in methylmethacrylate (MMA). The temperature 
was controlled by placing the jars in a water bath at room temperature to prevent bubble 
formation in the samples. After polymerization in MMA, non-decalcified sections (10 µm 
thickness) were prepared in the transversal direction perpendicular to the main axis of the 
cavity using a diamond blade saw microtome. Six histological sections, three close to the 
distal (d) or proximal (p) hole and three close to the medial part (m), were made for each half 
tibia and were stained with methylene blue and basic fuchsin. 
The remaining specimens (n = 11 distal parts (D); and n = 11 proximal parts (P)) were 
decalcified for 3 days. Each half tibia was cut in two halves, i.e. proximal (p) and medial (m) 
side for the proximal parts (P), and medial (m) and distal (d) side for the distal parts (D)), 
which were subsequently embedded in paraffin. Twelve transversal microtome sections (six 
distal (d) or proximal (p), and six medial (m); 6 µm thickness) were made and stained with 
Hematoxilin and Eosin (HE) and Elastica-Von Gieson (EVG) stain. 
The light microscopical evaluation of all sections was done using an optical microscope (Axio 
Imager Microscope Z1, Carl Zeiss Micro imaging GmbH, Göttingen, Germany) and consisted 
of an assessment of material remnants and a complete morphological description of the tissue 
response to different treatments, including primary bone remodeling and marrow restoration. 
Histomorphometrical analysis was conducted for at maximum six different EVG-stained cross 
sections, each section containing two halves (6p and 6m, or 6d and 6m), resulting in a total of 
twelve measurements per specimen. The region of interest (ROI) was identified by drawing a 
line around the endosteal border of cortical bone (i.e. the border adjacent to the medullary 
cavity), and the percentage of newly formed bone within the ROI was scored using a 
computer-based image analysis technique (The Leica® Qwin Pro-image analysis system, 
Wetzlar, Germany). The measurements of all sections for each samples were averaged. 
 
2.6.3. EDS analysis  
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MMA sections of OPF-CaP treated tibia (50-100 µm thick) at the proximal, medial and 
distal positions at 8 weeks of injection as well as a representative section of an OPF-CaP 
treated tibia ex vivo (used as reference) were processed for elemental mapping using a 
diamond saw. The elemental analysis was carried out using a Scanning Electron Microscope 
(Philips XL30, Eindhoven, the Netherlands) equipped with an Energy Dispersive 
Spectrometer (EDS, EDAX, AMETEK Materials Analysis Division, Mahwah NJ, USA). To 
improve the surface conductivity of the samples, a thin gold layer was deposited on the 
samples using a common sputtering instrument (Cressington 108A, Watford, England, UK). 
EDS analysis provided information on the distribution of elements of interest (Ca, P, O and C) 
and the atomic fraction of each element in the analyzed area. The atomic fraction of each 
element was presented as percentage with respect to other elements of interest (i.e. Ca + P + 
O + C = 100%). The associated error for all the EDS analyses was calculated to be less than 
10%. 
 
2.7. Statistical analysis 
 
Statistical analysis was performed with GraphPad Instat version 3.06 (GraphPad Software, 
San Diego CA, USA), using one way ANOVA combined with a post-hoc Tukey-Kramer 
Multiple Comparisons Test to detect statistically significant differences at a significance level 
(p-value) of p<0.05. Results are presented as means ± standard deviations. 
 
3. Results 
 
3.1. Macroscopic observation on experimental animals 
 
Two guinea pigs in OPF group were euthanized after 6 days due to clear evidence of stress 
and respiratory problems, resulting in loss of four OPF implanted subcutaneous scaffolds and 
two OPF-treated tibias. All the remaining animals, after a short-term weight loss, regained 
average weight and normal movement within 1 week post-surgery. At implant retrieval, no 
clinical signs of inflammation or infection (i.e. swelling or redness) were observed upon 
visual inspection of the treated hind limbs and in the dorsum of the animals. Table 4 depicts 
the number of subcutaneous scaffolds and tibias that were retrieved after the experimental 
period, and included for microCT and histological/histomorphometrical analyses. All 
implanted scaffolds could be retrieved and used for histological analysis. During processing 
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of the tibias, one medial side (m) of sham group, one proximal side (p), one medial side (m) 
and two distal sides (d) of OPF-CaP group were damaged and could not be used for 
histological/histomorphometrical analyses. 
 
3.2. Subcutaneous scaffolds 
 
3.2.1. Descriptive histology and histomorphometrical analysis 
 
Gross observation of HE-stained sections of subcutaneous scaffolds after 8 weeks of 
implantation showed a loose structure for plain OPF (Fig. 3a), and a compact structure for 
OPF-CaP hydrogels (Fig. 3d). At higher magnification, examination of the internal structure 
revealed a substantial cell infiltration (i) throughout the entire OPF scaffolds (Fig. 3b) and a 
dense mass without cells for OPF-CaP scaffolds (Fig. 3e). A thin fibrous capsule (Fc) 
surrounding OPF hydrogels was composed by elongated fibroblasts with oval nuclei and all 
orientated in the same direction (Fig. 3c). Differently, OPF-CaP hydrogels were surrounded 
by a thin fibrous capsule formed by fibroblasts with oval nuclei (Fc) adjacent to an equally 
thin capsule layer of cells with round nuclei (i) directly in contact with the hydrogel scaffold 
(H) (Fig. 3f).  
The results of the histomorphometrical analyses are presented in Fig. 3g. Based on the scoring 
system used for the qualitative (Fig. 3g-i) and quantitative (Fig. 3g-ii) evaluation of fibroblast 
capsule surrounding the scaffolds, a fibrous tissue, not dense, resembling connective tissue 
and consisting of approximately 5 fibroblast layers was observed surrounding both hydrogel 
types. 
 
3.3. Tibias 
 
3.3.1. Model validation 
 
Fig. 4a shows a representative image of the anatomy and MMA sections of the internal 
structure at different regions of a guinea pig tibia. The anatomy of the tibia resembles an 
irregular inverted cone, with a trapezoid shape of the cross-section in the proximal part (~5.0 
mm central axis), an oval shape of the cross-section in the middle part (~4.0 mm Ø), and a 
circular shape of the cross-section in the distal part of the tibia (~3.0-3.5 mm Ø). The 
thickness of cortical bone surrounding the cavity varies from ~0.4-1.0 mm in the proximal 
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side up to ~1.0-1.6 mm in the distal part where the cavity diameter is smaller. The cavity 
space is occupied by bone marrow. 
In view of model validation, two small holes (1.8 mm Ø) close to the proximal (P) and distal 
metaphysic (D) were made ex vivo at a distance of about 2 cm from each other (Fig. 4b). 
Light microscopy examination of MMA-embedded tibias filled with OPF-CaP hydrogel ex 
vivo proved the ability of the material to completely fill the tibial medullary space and to 
adapt to the irregular shape of the cavity when initially injected (Fig. 4b-i). Nevertheless, 2D 
and 3D microCT imaging of same samples showed that the material was hardly detected due 
to the low radiodensity relative to the threshold limit of the system (Fig. 4b-ii). 
Fig. 4c shows microCT analysis related to the radiopacity value within the VOI of sham, OPF 
and OPF-CaP-treated tibias ex vivo, and to the cavity length (mm) and volume (mm3) 
between the proximal and distal holes of treated tibias in vivo. For all these parameters, 
similar values were measured for all groups (p>0.05), i.e. ~21 mm for the cavity length and 
~81 mm3 for the cavity volume. 
 
3.3.2. Bone tissue response 
 
3.3.2.1. MicroCT 
 
Fig. 5a shows the microCT results at 8 weeks. The VOI in microCT analyses is 
schematically depicted in Fig. 5a-i. Different from ex vivo treated tibias, the 2D grayscale 
cross-sectional images of OPF-CaP-treated tibias after 8 weeks showed areas of increasing 
radiopacity from the proximal to the distal region. The grey color was converted to green 
color to visualize the areas of radiopacity within the VOI in the 3D-reconstructed models (Fig. 
5a-ii). Analysis of microCT scan gray values showed comparable results between the groups 
(sham 30.6 ± 10.3%; OPF 22.1 ± 9.6%; OPF-CaP 27.2 ± 10.8%) (Fig. 5a-iii). 
 
3.3.2.2. Descriptive histology and histomorphometrical analysis 
 
The histological and histomorphometrical results at 8 weeks are reported in Fig. 5b. The 
ROI in histological and histomorphometrical analyses are schematically depicted in Fig. 5b-i. 
HE-stained histological sections of sham, OPF and OPF-CaP treated tibias at the proximal, 
medial and distal regions showed different scenarios between the groups and even between 
the same group (sections separated by dotted lines), as described in detail below (Fig. 5b-ii).  
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Sham In the proximal region, either solely fatty marrow or bone trabecular islands with 
varying thickness were evident throughout the marrow space. The medial area was remodeled 
into relatively long and dense trabeculae containing a moderate number of fat cells. At the 
distal site, a very thick callus tissue bridging the cortical bone containing connective tissue 
and few cellular marrow was observed. 
OPF The proximal region was comparable to sham-treated specimens, i.e. either only 
filled with mature marrow or thin trabecular islands surrounded by cellular marrow. In the 
medial and distal region, three out of six marrow cavities showed OPF hydrogel (H) within 
the medullary bone; the other three tibias showed only thin trabeculae disconnected from each 
other, highly cellular marrow and no material remnants.  
OPF-CaP The proximal region was comparable to proximal regions in sham and OPF-
treated tibias. The material was no longer detected. In the medial and distal region of three out 
of eight OPF-CaP treated tibias, hydrogel (H) remnants were present, surrounded by 
immature and cellular marrow. In addition, some distal regions showed distinct cell-free 
calcified areas (dark purple color in the boxed region). All the other samples (5/8) did not 
show hydrogel material remnants, but rather a thickening of trabeculae, extending from the 
cortical border, matched with a gradual depletion of fatty cells in the marrow. 
The newly formed bone, including the new bone in direct contact to the surrounding cortical 
bone and the trabecular structures within the medullary cavity, was measured within the ROI. 
The total amount of new bone was comparable between the sham (27.7 ± 16.9%), OPF (14.0 
± 7.8%) and OPF-CaP (13.8 ± 9.5%) (Fig. 5b-iii). Specifically, all groups showed a higher 
percentage of newly formed bone in the medial region and the distal region compared to the 
proximal regions. However, only sham showed statistical differences (p < 0.05) between the 
distal (41.3 ± 23.8%) and proximal (8.7 ± 10.6%) regions. 
 
3.3.2.3. EDS analysis 
 
The amount of phosporous (P) and calcium (Ca) in arbitrary regions within the medullary 
cavities of OPF-CaP treated-tibias after 8 weeks was observed to be different from the 
composition of the ex vivo-OPF-CaP treated tibia (Figure 6a-i). Importantly, the relative 
amounts of P and Ca were lowest in the proximal region and highest in the distal region (Fig. 
6a-ii). 
The mapping of elements (Fig. 6b) within the medullary cavities showed that P and Ca were 
hardly detected in the ex vivo-treated tibia as well as in the proximal region of in vivo-treated 
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tibia after 8 weeks. Differently, large accumulation of P and Ca were evident in the medial 
and distal regions of in vivo-treated tibia after 8 weeks. 
 
4. Discussion 
 
The present study aimed to evaluate the soft tissue response and osteogenic performance of 
plain OPF hydrogels and OPF hydrogels enriched with CaP nanoparticles, using both 
subcutaneous implantation of pre-set scaffolds and injection of hydrogel precursor solutions 
into the tibial medullary cavity of guinea pigs. Incorporation of CaP nanoparticles was 
explored as a mimic of the inorganic phase of bone, for which we hypothesized that OPF-CaP 
hydrogels would outperform plain OPF hydrogels in terms of tissue response and bone 
forming capacity. The results of this study indicated similar biocompatibility for both types of 
pre-set OPF-based scaffolds, although OPF-CaP maintained a dense structure and reduced 
cellular infiltration as well as material degradation compared to OPF scaffolds. The tibial 
marrow ablation model in guinea pigs represented a simple and reproducible surgical 
technique and allowed an adequate volume (~ 81 mm3) for application of hydrogels in 
injectable formulation. At 8 weeks following ablation, new trabecular bone was formed in all 
tibias, but the bone remodeling and bone marrow restoration varied between the different 
regions within the medullary cavity. Importantly, hydrogel remnants were still present in only 
few tibias and, for OPF-CaP group, highly calcified areas were found in the distal region as a 
result of aggregation and sedimentation of CaP nanoparticles upon implantation. 
Previous work using OPF-based hydrogels demonstrated the biocompatibility of these 
materials and their degradation products [9,12,28]. Similarly, in this study, both types of OPF-
based hydrogels evoked a mild tissue response after 8 weeks of implantation. Nevertheless, 
OPF scaffolds presented a loose structure combined with a remarkable number of infiltrating 
cells and pronounced degradation, as a result of a high water content (~ over 90% of w/v). 
Differently, the dense structure of OPF-CaP scaffolds was maintained by both the presence of 
homogeneously distributed CaP nanoparticles throughout the polymeric matrix and reduced 
water content (approximately two times less than OPF hydrogels [16,29].  
While earlier studies used pre-formed OPF-based hydrogels to test the regenerative  potential 
in osteochondral and bone defects [9,12,28], the current study was the first attempt to evaluate 
the in vivo performance of these materials as injectable formulation. 
The literature describes the use of injectable bone substitute materials in animal models either 
for bone defect repair or bone augmentation. Specifically, bone defects are generally created 
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by drilling into or removing parts of intact bone tissue, whereas bone augmentation 
procedures are performed to obtain an increased amount of high quality bone. Although a few 
models in small animals (e.g. mouse and rat calvaria, epiphysis or diaphysis) are clinically 
feasible for injectable bone substitute materials, none of those allows injection of substantial 
amounts of materials. For instance, full thickness or partial craniotomies are not suitable for 
injectable hydrogels as they might penetrate inside the brain or leak out of the defect after 
scaffold swelling. Similarly, the diaphysis or epiphysis of long bones of mice and rats is not 
suitable for direct injection of in situ crosslinkable materials due to too small diameter 
incisions, too small diameter needles and too low cavity volume [30]. Consequently, the tibial 
marrow ablation model in guinea pigs was considered to be the smallest animal that would 
offer a reservoir with adequate capacity for material injection (~1 ml of hydrogels). As new 
bone formation was induced in a space (i.e. the medullary cavity) where bone tissue is not 
normally present, this model served to test the potential use of OPF-based hydrogels for bone 
augmentation application. Specifically, mechanical emptying of the medullary cavity of a 
tubular bone triggers endosteal bone formation [17,31] because of the osteogenic potential of 
the endosteum, i.e. a thin layer of connective tissue surrounding the bone marrow spaces [32]. 
After marrow removal, the blood clot fills the diaphyseal medullary cavity and releases 
several osteogenic growth polypeptides, such as insulin-like growth factor (IGF-I), and 
osteogenic growth peptide (OGP), which mediate the replacement with primary trabecular 
bone (the so-called initial intramedullary osteogenic phase) [33,34]. The formation of bone 
progresses centripetally, i.e. from the cortical endosteal surface towards the center of the 
medullary cavity, until reaching almost complete filling with transient trabecular mesh at the 
peak of the osteogenic phase. Subsequently, the bone trabeculae are subjected to osteoclastic 
resorption and replacement by new marrow, which is identical to the original tissue that was 
removed (the so-called second osteogenic phase) [35,36]. In rats, the entire process is 
completed within 35 days [2]. Not surprisingly, in this study consistent amounts of new bone 
were formed in the sham group and the process was not complete after 8 weeks, as guinea 
pigs have substantially larger long bones and lower metabolic activity compared to rats. 
Little is known about the impact of bone graft materials on the formation of primary bone 
within the marrow cavity. According to a previous study, chemical composition and structural 
properties of bone graft materials affect both the rate and extent of primary bone formation, 
and influence the quality and rate at which marrow regeneration occurs [2]. As mentioned 
above, the present study was initiated to test for the first time OPF-based hydrogels in 
injectable formulations in vivo. Similar to the pre-set scaffolds, the excellent tolerability of 
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such materials was confirmed in the tibia as no signs of prolonged inflammatory response nor 
leg swelling were observed. Histological evaluation showed new bone formation in all tibias 
and presence of material remnants in only few specimens. More surprisingly, unexpected dark 
and dense regions were observed in the distal tibias of OPF-CaP group as indication of 
heterogeneously calcified areas, suggesting the aggregation and sedimentation of CaP 
nanoparticles. This hypothesis was corroborated by EDS analysis which attested the presence 
of much higher amounts of phosphorous and calcium, the major components of CaP minerals, 
in the distal regions compared to the medial and proximal regions. 
Summarizing, these findings raised two different assumptions: (i) hydrogel formation from 
flowable aqueous solutions was hampered in a highly perfused environment, like the 
medullary cavity [37], which might have caused sedimentation of aggregated CaP 
nanoparticles in the distal region of the tibias, or ii) degradation of the polymeric hydrogel 
matrix proceeded faster than degradation of the nanostructured mineral phase resulting into 
loss of entrapment of the CaP nanoparticles and subsequent sedimentation into the distal parts 
of the tibia. Both assumptions were supported by the similar amounts of bone formation as 
measured in sham and hydrogel treated-tibias after 8 weeks. Specifically, the disappearance of 
OPF-based hydrogels from the medullary cavity, either because of lack of in situ gelation (1st 
assumption) or too fast degradation (2nd assumption), evoked a comparable outcome for 
sham and hydrogel-treated tibias. To verify whether the in vivo environment negatively 
influenced the gelation of OPF-based matrices, a simple additional gelation study was 
performed. Specifically, the gelation efficiency in both wet and dry environments was tested 
under both static and dynamic conditions (see Supplementary Information for further 
experimental details). Under dry conditions, all OPF-based hydrogels formed within 15 min. 
Figure 7 shows the dry mass percentage of hydrogels formed in a wet environment under 
static (0 rpm) and dynamic conditions (60, 150 and 300 rpm) relative to the mass of gels 
formed in a dry environment at static conditions (0 rpm). It was observed that CaP 
nanoparticles exhibited a stabilizing effect on OPF-CaP hydrogel integrity, while the gelation 
of OPF hydrogels was considerably compromised by increasing the shaking speed from 0 to a 
maximum value of 300 rpm. These data suggested that formation of OPF-based hydrogels can 
be hampered under highly perfused (i.e. wet and highly dynamic) conditions. Since the 
experimental conditions of this preliminary in vitro study do not reflect the complexity of the 
physiological environment, it was not possible to correlate the findings of the vitro gelation 
study to the in vivo study, which warrants the development of a suitable in vitro test that can 
predict the gelation behavior of hydrogels in vivo. 
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Two different analytical techniques, i.e. conventional micro-CT and histomorphometry, were 
used for the quantification of new bone formation within the tibial medullary cavity after 8 
weeks of injection. Observation of the results demonstrated that both techniques showed a 
similar trend. However, regarding the hydrogels-treated tibias, the percentage of bone as 
measured by micro-CT was higher compared to the histomorphometrical outcomes. This 
mismatch might be explained by the different principles of the approaches applied [38]. For 
instance, destructive 2D methods allowed for more accurate measurements due to the ability 
to discriminate between cortical bone and adjacent newly formed bone, and between 
trabecular structures and remnants of highly calcified material within the cavity. On the other 
hand, histological techniques limited the quantification on only a few representative sections 
of the three distinct areas (i.e. proximal, medial and distal regions of the tibia). Differently, 
non-destructive 3D analysis examined the entire tibias thus yielding an exhaustive evaluation. 
However, the indistinguishable gray level values between new bone and the highly calcified 
area in the distal region of OPF-CaP treated tibias undoubtedly contributed to increase the 
value of radiopacity in the samples thus to result in an overestimation of bone formation. 
 
5. Conclusion 
 
Biocompatibility and osteogenic capacity of OPF and OPF-CaP hydrogels were 
investigated through ectopic implantation of preset scaffolds and injection of flowable 
hydrogel precursor solutions in a tibial ablation model, respectively. Specifically, the results 
showed a thin and relatively mature fibrous capsule surrounding both types of subcutaneous 
scaffolds, although the presence of CaP nanoparticles was observed to limit degradation and 
cellular invasion. Bone formation in the medullary cavity, which is a site predisposed to form 
bone, demonstrated to be equal for both groups after 8 weeks. However, the presence of 
highly calcified areas in the distal region of OPF-CaP treated tibias, as a result of CaP 
nanoparticles sedimentation and agglomeration, suggested incomplete gelation of the 
injectable hydrogels in vivo. Based on these observations, the high flowability and 
uncontrolled gelation within the complexity of the physiological environment seemed to be 
the major critical factors for the application of OPF-based hydrogels in injectable formulation. 
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Captions 
 
Fig. 1 Tibial marrow ablation surgery and hydrogel injection in guinea pigs. (a) Exposed 
distal and proximal holes; (b) bone marrow (arrow) flushed from the medullary 
cavity; (c) hydrogel injection through a syringe connected to a catheter needle. 
Fig. 2  Sample processing for histological and histomorphometrical analysis. Specimens 
were cut in half, i.e. proximal tibia (P) and distal tibia (D), and alternatevely 
embedded in MMA and paraffin. For instance, for tibia 1 the proximal tibia (P1) was 
embedded in MMA and distal tibia (D1) was embedded in paraffin. For tibia 2, 
proximal tibia (P2) was embedded in paraffin and distal tibia (D2) was embedded in 
MMA. For MMA-embedded samples, six sections (3 proximal (p) and 3 medial (m) 
or 3 medial (m) and 3 distal (d)) were obtained. Paraffin-embedded samples were cut 
in half and twelve sections (6 medial (m) and 6 distal (d) or 6 proximal (p) and 6 
medial (m)) were obtained. 
Fig. 3 (a-d) HE-stained histological sections showing overview of OPF and OPF-CaP 
subcutaneous scaffolds at 8 weeks (scale bars = 500 µm). (b-e) Internal stucture 
(scale bars = 100 µm) and (c-f) fibrous capsule surrounding OPF and OPF-CaP 
scaffolds at higher magnification (scale bar = 50 µm). H: hydrogel, i: infiltrated cells, 
Fc: fibrous capsule. (g) Histological scoring of (i) quality and (ii) thickness of fibrous 
capsule surrounding OPF and OPF-CaP scaffolds at 8 weeks. Results represent the 
means ± standard deviations of 6 scaffolds (n sections=6) per condition. 
Fig. 4 (a) Macroscopic image and MMA-histological sections of the internal structure of a 
native tibia of guinea pig. (b) Macroscopic image, (i) MMA-histological sections and 
(ii) 2D and 3D-reconstructed microCT images of a OPF-CaP treated-tibia ex vivo. 
(c) Radiopacity (%) within the medullary cavity of sham, OPF and OPF-CaP treated 
tibias ex vivo, and cavity volume (mm3) and length (mm) of same groups treated in 
vivo, as determined with microCT. Error bars represent means ± standard deviation. 
Fig. 5 (a) (i) Schematic representation of the VOI (i.e. the area included between the 
proximal and distal hole) for microCT analyses; (ii) 2D and 3D-reconstructed 
microCT images of the medullary cavity of a tibia filled with OPF-CaP hydrogels 
after 8 weeks and (iii) measurements of radiopacity (%) within VOI of sham, OPF 
and OPF-CaP treated tibias after 8 weeks. (b) (i) Schematic illustration of the 
positions of three ROI (proximal, medial and distal) within the medullary cavity for 
histological and histomorphometrical analysis. (ii) HE-stained sections of sham, OPF 
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and OPF-CaP tibias at three different regions (scale bars = 1000 µm). Dotted lines 
discriminates two different conditions belonging to the same group. Boxed region 
shows highly calcified areas (dark purple color) in the distal region of OPF-CaP 
treated-tibias (scale bar = 100 µm). (iii) Results of histomorphometrical and 
statistical analysis of new bone formation (%) displayed for the total of the three 
zones and for the single zones. *refers to (p < 0.05). Error bars represent means ± 
standard deviation.  
 
Fig. 6 (a) (i) MMA sections (scale bars = 1000 µm) and (ii) amount of phosphorous (P) and 
calcium (Ca) in arbitrary regions (black square) within the cavity of OPF-CaP treated 
tibias ex vivo and after 8 weeks as determined with EDX analyses. (b) Distribution of 
elements in the representative regions. Carbon (C) and oxygen (O) represent the 
organic matrix, phosphorous (P) and calcium (Ca) represent the CaP minerals.  
 
Fig. 7 Dry mass of OPF and OPF-CaP hydrogels formed under wet conditions at different 
shakig speeds (0, 60, 150 and 300 rpm) calculated as the percentage of the control 
group (i.e. hydrogels formed in dry conditions at 0 rpm). *** p < 0.001 related to OPF 
at 0 rpm.  +++ p < 0.001 related to OPF-CaP at 0 rpm. Error bars represent ± standard 
deviation. 
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Table 1 Experimental groups used in this study. 
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Table 2 Components and relative amounts for CaP-free (OPF) and CaP-enriched (OPF-CaP) hydrogels preparation. 
 
 
 OPF OPF-CaP 
OPF (g) 0.15 0.15 
PEGDA (g) 0.075 0.075 
PBS (µl) 860 - 
CaP suspension (µl) - 860 
0.3 M APS (µl) 70 70 
0.3 M TEMED (µl) 70 70 
Total volume (µl) 1000 1000 
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Table 3 Histological grading scale for capsule quality and thickness. 
 
 
 
Histological grading scale for capsule quality Score
Capsule tissue is fibrous, not dense, resembling connective or fat tissue in the 
noninjured regions 
4 
Capsule tissue is fibrous but immature, showing fibroblasts and little collagen 3 
Capsule tissue is granulous and dense, containing both fibroblasts and many 
inflammatory cells 
2 
Capsule tissue consists of masses of inflammatory cells with little or no signs of 
connective tissue organization 
1 
Cannot be evaluated because of infection or other factors not necessarily related to the 
material 
0 
Histological grading scale for capsule thickness Score
1-4 fibroblasts 4 
5-9 fibroblasts 3 
10-30 fibroblasts 2 
>30 fibroblasts 1 
Not applicable 0 
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Table 4 Number of subcutanoeus scaffolds and tibias retreived for each group and number of samples used for the respective analyses (P: 
proximal tibia; D: distal tibia; p: proximal side, m: medial side, d: distal side). 
 
 
